Brightsurf Science News and Current Science News Events
 
Email a Friend Send to a friend
Printer Friendly Print Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer

Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer

February 15, 2008

New understanding of a protein that spurs the growth of pancreatic cancer could lead to a new vaccine against the deadly disease, said researchers at Baylor College of Medicine in Houston in a report appearing in the current edition of the journal Molecular Cancer Therapeutics.

The protein called mesothelin appears to play an important role in promoting pancreatic cancer growth, said the senior author Dr. Qizhi (Cathy) Yao, professor of surgery - vascular surgery at BCM. She, along with co-lead authors Dr. Min Li, assistant professor of surgery, and research associate Dr. Uddalak Bharadwaj carried out the studies of the protein that is found on the tumor cells' surface.




"Mesothelin is found in other cancers for several years," said Yao, also a researcher in the Dan L. Duncan Cancer Center at BCM. "However, we didn't know the role it played in pancreatic cancer:" until she and her colleagues reported in this article. In fact, they found very high levels of mesothelin in 18 of 21 samples of patient's pancreatic tissues compared to amounts found in nearby normal tissues. In studies of this protein in the lab, pancreatic cancer cell lines that produced high levels of mesothelin grew faster and spread more than those in which mesothelin levels were lower.

Pancreatic cancer cells grew and spread faster in mice whose tumors expressed high levels of mesothelin than in those whose cancer did not, said the researchers, who conducted the studies in an immune deficient mouse.

"We saw this molecule as very significant in the life of the tumor cells," Yao said. "Our next step is to identify whether this would be a good active immunotherapy target."

Making a treatment vaccine of virus-like particles (VLPs) that contained mesothelin, researchers injected mice having pancreatic cancer with this vaccine three times. Virus-like particles have the unique property of inducing protective immune responses but they lack the infectious capacities of the original virus.

Tumor growth in the immunized mice slowed and in some cases the tumor disappeared. The average life span for the mice not treated was four weeks. The immunized mice survived five weeks longer than those not treated.

Researchers found that the immunization works by suppressing production of key immune system cells that suppress the body's ability to fight the tumor. The researchers said pancreatic cancers produce these cells, called T regulatory cells, as a protective measure.

"If we are able to see the same results in humans, this would allow us to incorporate a combination therapy to treat the tumor," Yao said. "Treatment with a single drug is not effective."

Yao and her colleagues are seeking U.S. Food and Drug Administration approval to begin studies using their vaccination on people suffering from pancreatic cancer.

Baylor College of Medicine



Related Pancreatic Cancer News Articles Pancreatic Cancer News and Current Pancreatic Cancer Events RSS Pancreatic Cancer News and Current Pancreatic Cancer Events RSS
Endoscopic ultrasound highly accurate in evaluating ambiguous radiographic findings of the pancreas
Researchers from St. Louis University School of Medicine in Missouri report that EUS and EUS-FNA is 99.1 percent accurate in diagnosing pancreatic neoplasms (abnormal growths or tumors) in patients who were referred for endoscopic ultrasound (EUS) because of CT and/or MRI reports of two common, though somewhat ambiguous findings - enlargement of head of pancreas (HOP) or dilation of the pancreatic duct (PD).

VCU Massey Cancer Center and VCU Institute of Molecular Medicine Researchers Publish Findings of a New Chemoprevention Gene Therapy That Kills Pancreatic Cancer Cells
Researchers at the Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have published findings that implicate a new chemoprevention gene therapy (CGT) for preventing and treating pancreatic cancer, one of the most lethal and treatment-resistant forms of cancer.

Checking more lymph nodes linked to cancer patient survival
Why do patients with gastric or pancreatic cancer live longer when they are treated at cancer centers or high-volume hospitals than patients treated at low-volume or community hospitals?

Cancer centers and high-volume hospitals may examine more lymph nodes in cancer patients
Patients with gastric or pancreatic cancer appear to have more lymph nodes examined for the spread of their disease if they are treated at hospitals performing more cancer surgeries or those designated as comprehensive cancer centers.

Certain anticancer agents could be harmful to patients with heart disease
A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis.

OHSU Discovery May Lead to Early Cancer Detection
OHSU pancreatic cancer expert Brett Sheppard, M.D., and colleagues in the OHSU Oregon Stem Cell Center, have developed antibodies that recognize pancreatic cancer; Sheppard is presenting these findings this week during Digestive Disease Week in San Diego.

Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
An herb used in traditional medicine by many Middle Eastern countries may help in the fight against pancreatic cancer, one of the most difficult cancers to treat.

UAB Study Shows Drug May Fight Biliary Cancers
Laboratory studies by University of Alabama at Birmingham (UAB) researchers have shown that the drug triphendiol (NV-196) causes cell death in pancreatic and bile duct cancer cell lines, slows tumor growth and sensitizes tumors to chemotherapy treatments.

Salivary diagnostics, the 'magic mirror' to your health ... at your personal computer
Accuracy, convenience, and non-invasiveness are the most critical characteristics for any diagnostic tool. A new concept, Salivaomics Knowledge Base (SKB), an in silico (i.e., performed on computer or via computer simulation) saliva diagnostic atlas, is launching today during the 37th Annual Meeting of the American Association for Dental Research in Dallas, Texas.

Genetic variations raise lung cancer risk for smokers and ex-smokers
Two common inherited genetic variations are associated with increased risk of lung cancer for smokers and former smokers, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports April 2 in the online edition of Nature Genetics.
More Pancreatic Cancer News Articles


The Last Lecture
by Randy Pausch, Jeffrey Zaslow

"We cannot change the cards we are dealt, just how we play the hand." --Randy Pausch A lot of professors give talks titled "The Last Lecture." Professors are asked to consider their demise and to ruminate on what matters most to them. And while they speak, audiences can't help but mull the same question: What wisdom would we impart to the world if we knew it was our last chance? If we had to...



100 Q&A About Pancreatic Cancer (100 Questions Series)
by O'ReillyfEileen

EMPOWER YOURSELF! Whether you’re a newly diagnosed pancreatic cancer patient, a survivor, or a friend or relative of someone with pancreatic cancer, this book offers help. The only text to provide a doctor’s and patient’s view, 100 Questions & Answers About Pancreatic Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life,...



The Official Patient's Sourcebook on Pancreatic Cancer: A Revised and Updated Directory for the Internet Age
by Icon Health Publications

This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to pancreatic cancer (also Cancer pancreas; Pancreatic cancer), from the...

Pancreatic Cancer (American Cancer Society Atlas of Clinical Oncology)
by John L. Cameron

At present, there are approximately 28,300 new cases of pancreatic cancer in the United States. It is the fourth leading cause of cancer death in men and women. Approximately 2 out of 10 patients with cancer of the pancreas will live at least one year after the cancer is found, but only a very few will survive for five or more years. The editors have brought together a stellar team of...



My Journey With Pancreatic Cancer
by Calvin E. Rains Sr.

This book is shared to help all understand the cancer affecting the pancreas which is a vital organ in the digestion of food. Pancreatic cancer is one of the most deadly of cancers affecting the human body. Less than 5% of those diagnosed with Pancreatic Cancer survive the first year. This book is intended to help the patient, their families, and friends to understand the dangers and possible...



The Pancreas: An Integrated Textbook of Basic Science, Medicine and Surgery
by Hans-Gunther Beger, Markus Buchler, Richard Kozarek, Markus Lerch, John Neoptolemos, Andrew Warshaw, David Whitcomb, Keiko Shiratori

The encyclopedic guide to the pancreas for practicing clinicians and surgeonsIn the past decade extraordinary developments in diagnostic and therapeutic radiology and endoscopy have been coupled with major advances in surgical techniques and basic sciences. As a result the management of pancreatic disorders is now handled by a multidisciplinary team. This book shows you how to achieve superior...



Pancreatic Cancer (M.D. Anderson Solid Tumor Oncology Series)

The MD Anderson Solid Tumor Oncology series presents the most cutting-edge surgical treatment and medical therapy for specific sites. Each year, more than 26,000 people are diagnosed with pancreatic cancer, also called a "silent" disease because it does not usually exhibit early symptoms. This volume defines the current standard on multimodality care: surgery, chemotherapy, immunotherapy, gene...



21st Century Complete Medical Guide to Pancreatic Cancer and Islet Cell Carcinoma - Authoritative Government Documents and Clinical References for Patients ... on Diagnosis and Treatment Options
by PM Medical Health News

This up-to-date and comprehensive CD-ROM provides a superb collection of official Federal government documents on pancreatic cancer and islet cell carcinoma: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. There is no other reference that is as fast, convenient, and portable - everything...



Pancreatic Cancer (M.D. Anderson Solid Tumor Oncology Series)

Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical...

Quickfacts Pancreatic Cancer (Quickfacts)
by American Cancer Society

What you need to know about Pancreatic Cancer Different kinds of cancer can behave very differently. That's why people with cancer need treatment that is aimed at their own specific kind of cancer. ACS's QuickFACTS™ gives you what you need to know, right from the start, about your specific cancer-type. They're authoritative, comprehensive, and quick reads (including a concise...

© 2008 BrightSurf.com